Scrip: industry news and insights
Almirall Views Vitiligo As Next Dermatology Opportunity
By Kevin Grogan 18 May 2022
As it prepares to file lebrikizumab for atopic dermatitis, the Spanish group is looking to expand into vitiligo through a...
Focusing on how pharma is responding to litigation, deals, and more in the face of the opioid crisis. Download your free Scrip article pack, featuring:
Scrip: industry news and insights
By Kevin Grogan 18 May 2022
As it prepares to file lebrikizumab for atopic dermatitis, the Spanish group is looking to expand into vitiligo through a...
Scrip: industry news and insights
18 May 2022
Ahead of the American Society of Clinical Oncology meeting in early June, analysts at Biomedtracker have highlighted select high-impact late-breaking...
Scrip: industry news and insights
18 May 2022
Despite promising clinical data and solid regulatory plans, biotech firms hoping to address the unmet need in Sanfilippo Syndrome through...
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: